Latest Insulin therapy Stories
Study suggests a new approach could give patients the ability to make their own insulin-producing cells without a stem cell transplant A study by Columbia researchers suggests that cells in the patient's intestine could be coaxed into making insulin, circumventing the need for a stem cell transplant. Until now, stem cell transplants have been seen by many researchers as the ideal way to replace cells lost in type I diabetes and to free patients from insulin injections. The...
Researchers at Washington University School of Medicine in St. Louis have identified a potent regulator of sensitivity to insulin, the hormone that controls blood sugar levels. The new findings may help scientists find better treatments for type 2 diabetes, obesity and other health problems caused by the body’s inability to properly regulate blood sugar. The research is published online Feb. 13 in PLoS ONE. Fat and muscle cells in patients with type 2 diabetes become resistant to...
JERUSALEM, January 24, 2012 /PRNewswire/ -- Marking a major milestone for the Company, Oramed Pharmaceuticals Inc. (OTCBB: ORMP) (http://www.oramed.com [http://us.lrd.yahoo.com/SIG=11adsmcif/EXP=1326899031/**http%3A/www.oramed.com ]), a developer of oral drug delivery systems, announced today that it has received approval for a key patent by the Australian Patent Office. The patent covers an important part of the Company's core technology which allows for the oral delivery of...
PHILADELPHIA, Jan. 24, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System for transdermal drug delivery, today announced that it is initiating clinical studies of its Symphony tCGM System in critical care patients. The company expects to complete and announce the results of the studies in the near term. "We...
Sucanon is a breakthrough herbal-based treatment of type 2 diabetes, which unlike traditionally used medication is not associated with side effects or harmful metabolic changes in the body. (PRWEB) January 20, 2012 Sucanon is a breakthrough herbal-based treatment of type 2 diabetes, which unlike traditionally used medication is not associated with side effects or harmful metabolic changes in the body. Although researchers were enthusiastic about Sucanon's ability to effectively address...
ALLENDALE, N.J., Jan. 12, 2012 /PRNewswire/ -- NeoStem's cell therapy manufacturing division, Progenitor Cell Therapy ("PCT"), a NeoStem, Inc. company (NYSE Amex: NBS) ("NeoStem" or the "Company"), announced today an agreement whereby PCT will provide contract manufacturing and regulatory services related to the development of Islet Sciences - PTM, which will be an injectable suspension of microencapsulated insulin-producing, pancreatic islet cells which are harvested from...
JERUSALEM, January 10, 2012 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com [http://us.lrd.yahoo.com/SIG=11adsmcif/EXP=1326899031/**http%3A/www.oramed.com ]), a developer of oral drug delivery systems, announced today that it has filed a provisional patent application with the United States Patent and Trademark Office for a combination therapy of its lead compound, ORMD-0801 in combination with its oral exenatide formulation, ORMD-0901. There...
The Endocrine Society releases new clinical practice guideline on the management of hyperglycemia in hospitalized patients in a non-critical care setting Hyperglycemia, or having high glucose levels in the blood, is a common, serious and costly health care problem in hospitalized patients. Today, The Endocrine Society released a clinical practice guideline (CPG) providing recommendations for practical and safe glycemic targets and describing protocols and system improvements required to...
The world diabetes care devices market was worth USD 16.2 billion last year and is forecast to grow at a CAGR of 6% to reach USD 24.3 billion in 2017. New market research report “Asia-Pacific Diabetes Care Devices Market Outlook to 2017 - Glucose Monitoring and Insulin Delivery” developed by GlobalData has been recently published by Market Publishers Ltd. London, UK (PRWEB) December 28, 2011 The world diabetes care devices market was worth USD 16.2 billion last year and is forecast to...
FARMINGTON, Conn., Dec. 1, 2011 /PRNewswire-iReach/ -- Global Information, Inc. (GII) presents Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 by GlobalData. (Photo: http://photos.prnewswire.com/prnh/20111201/CG15956) Insulin pump are small computer-driven mechanical devices that deliver insulin in a precisely controlled manner at pre-programmed intervals, and are extremely helpful to diabetic patients who need several daily injections of...
Latest Insulin therapy Reference Libraries
Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...
